Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer
NCT00089635
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
203
Enrollment
INDUSTRY
Sponsor class
Conditions
Colorectal Cancer
Metastases
Interventions
DRUG:
Panitumumab
Sponsor
Amgen